SCHEMBL14986928

SCHEMBL14986928

COC(=O)C1=C(C)N(C)C(C)=C(C(=O)OC)C1c1ccc(F)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.75
HSD17B10 Q99714 2/20 0.75
NPSR1 Q6W5P4 4/20 0.73
HPGD P15428 2/20 0.73
KDM4E B2RXH2 2/20 0.73
LMNA P02545 1/20 0.67
HTT P42858 2/20 0.62
GAA P10253 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.54
ALDH1A1 P00352 1/20 0.52
CASP1 P29466 1/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CACNA1F O60840 1/20 0.52
CACNA1D Q01668 1/20 0.52
CACNA1S Q13698 1/20 0.52
CACNA1C Q13936 1/20 0.52
TP53 P04637 2/20 0.49
POLB P06746 1/20 0.47
GPBAR1 Q8TDU6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8441842 0.94 TSHR (0.68) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL14987375 0.87 TSHR (0.79) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL9120044 0.85 NPSR1 (0.74) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL14987372 0.84 TSHR (0.75) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL9120916 0.84 TSHR (0.75) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL14986926 0.84 NPSR1 (1.00) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL14986931 0.84 TSHR (0.63) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL5363492 0.84 TSHR (0.74) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL7934386 0.84 TSHR (0.69) TSHRHSD17B10NPSR1HPGDKDM4E
SCHEMBL16186974 0.83 TSHR (0.53) TSHRHSD17B10NPSR1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660789-B2 1,4-dihydropyridine derivatives with HSP modulating activity RICHTER GEDEON NYRT. (HU) 2020-05-26 US disclosed
US-20190192336-A1 1,4-Dihydropyridine Derivatives With HSP Modulating Activity LIPIDART KUTATÓ FEJLESZTO ÉS TANÁCSADÓ KFT. (HU) 2019-06-27 US disclosed
US-10258498-B2 1,4-dihydropyridine derivatives with Hsp modulating activity RICHTER GEDEON NYRT. (HU) 2019-04-16 US disclosed
US-20140315893-A1 1,4- DIHYDROPYRIDINE DERIVATIVES WITH HSP MODULATING ACTIVITY RICHTER GEDEON NYRT. (HU) 2014-10-23 US disclosed
WO-2013076516-A1 1,4- DIHYDROPYRIDINE DERIVATIVES WITH HSP MODULATING ACTIVITY LIPIDART KUTATÓ FEJLESZTŐ ÉS TANÁCSADÓ KFT. (HU) 2013-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140315893-A1 1,4- DIHYDROPYRIDINE DERIVATIVES WITH HSP MODULATING ACTIVITY HSF1, HSPB1, HSP90AB1 TSHR 3760/4885HSD17B10 1168/4885NPSR1 660/4885
US-10258498-B2 1,4-dihydropyridine derivatives with Hsp modulating activity HSF1, HSPB1, HSP90AB1 TSHR 3760/4885HSD17B10 1168/4885NPSR1 660/4885
US-10660789-B2 1,4-dihydropyridine derivatives with HSP modulating activity HSF1, HSPB1, HSP90AB1 TSHR 3760/4885HSD17B10 1168/4885NPSR1 660/4885
US-20190192336-A1 1,4-Dihydropyridine Derivatives With HSP Modulating Activity HSF1, HSPB1, HSP90AB1 TSHR 3760/4885HSD17B10 1168/4885NPSR1 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.